These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7004811)

  • 21. Effect of blood glucose control on retinal vascular permeability in insulin-dependent diabetes mellitus.
    Bleicher SJ; Lee TY; Bernstein R; Schachter L; Temes R; Krupin T; Santiago J; Becker B; Waltman SR
    Diabetes Care; 1980; 3(1):184-6. PubMed ID: 6996963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The treatment of diabetes mellitus using continuous subcutaneous infusion].
    van Ballegooie E; Sluiter WJ; Reitsma WD; Doorenbos H
    Ned Tijdschr Geneeskd; 1980 Nov; 124(48):2038-42. PubMed ID: 7003403
    [No Abstract]   [Full Text] [Related]  

  • 23. Brittle diabetes: long-term control with a portable, continuous, intravenous insulin infusion system.
    Bayliss J
    Br Med J (Clin Res Ed); 1981 Nov; 283(6301):1207-9. PubMed ID: 6797511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin infusion via a portable pump.
    Orzeck EA
    Tex Med; 1980 Jul; 76(7):46-9. PubMed ID: 6994269
    [No Abstract]   [Full Text] [Related]  

  • 25. Intensive conventional and insulin pump therapies in adult type I diabetes. A crossover study.
    Nathan DM; Lou P; Avruch J
    Ann Intern Med; 1982 Jul; 97(1):31-6. PubMed ID: 7046554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ambulatory treatment of diabetes in children by continuous subcutaneous infusion of insulin using a portable pump].
    Bougnères PF; Landier F; Lemmel C; Golse B; Chaussain JL
    Arch Fr Pediatr; 1984 Jan; 41(1):27-33. PubMed ID: 6721650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement of high-density lipoprotein-cholesterol levels. Ambulatory type I diabetics treated with the subcutaneous insulin pump.
    Falko JM; O'Dorisio TM; Cataland S
    JAMA; 1982 Jan; 247(1):37-9. PubMed ID: 7031287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Portable insulin infusion pumps as an alternative means of insulin delivery in type I diabetes. Report on 11 patients.
    Distiller LA
    S Afr Med J; 1983 Mar; 63(13):475-9. PubMed ID: 6340223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of continuous subcutaneous insulin infusion on endogenous insulin secretion in type I diabetes.
    Pietri A; Alford M; Raskin P
    Diabetes Care; 1982; 5(3):330-3. PubMed ID: 6756842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accuracy assessment of online glucose monitoring by a subcutaneous enzymatic glucose sensor during exercise in patients with type 1 diabetes treated by continuous subcutaneous insulin infusion.
    Radermecker RP; Fayolle C; Brun JF; Bringer J; Renard E
    Diabetes Metab; 2013 May; 39(3):258-62. PubMed ID: 23522730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversal of neuropathic and gastrointestinal complications related to diabetes mellitus in adolescents with improved metabolic control.
    White NH; Waltman SR; Krupin T; Santiago JV
    J Pediatr; 1981 Jul; 99(1):41-5. PubMed ID: 7019402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged peritoneal insulin infusion in a diabetic man.
    Schade DS; Eaton RP; Friedman NM; Spencer W
    Diabetes Care; 1980; 3(2):314-7. PubMed ID: 6993146
    [No Abstract]   [Full Text] [Related]  

  • 33. Haemoglobin A1: An indicator of the metabolic control of diabetic patients.
    Gonen B; Rubenstein A; Rochman H; Tanega SP; Horwitz DL
    Lancet; 1977 Oct; 2(8041):734-7. PubMed ID: 71541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraperitoneal delivery of insulin by a portable microinfusion pump.
    Eaton RP; Friedman NM; Spencerr WJ
    Metabolism; 1980 Aug; 29(8):699-702. PubMed ID: 6995791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of ambulatory unstable diabetic patients by continuous subcutaneous infusion of insulin: preliminary results (author's transl)].
    Lambert AE; Buysschaert M; Van Halle B
    Diabete Metab; 1979 Dec; 5(4):307-12. PubMed ID: 398299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of juvenile-onset diabetes by subcutaneous infusion of insulin with a portable pump.
    Sherwin RS; Tamborlane WV; Genel M; Felig P
    Diabetes Care; 1980; 3(2):301-8. PubMed ID: 6993144
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy of real-time continuous glucose monitoring on glycaemic control and glucose variability in type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy: a randomized controlled crossover trial.
    Tumminia A; Crimi S; Sciacca L; Buscema M; Frittitta L; Squatrito S; Vigneri R; Tomaselli L
    Diabetes Metab Res Rev; 2015 Jan; 31(1):61-8. PubMed ID: 24816997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restoration of normal lipid and aminoacid metabolism in diabetic patients treated with a portable insulin-infusion pump.
    Tamborlane WV; Sherwin RS; Genel M; Felig P
    Lancet; 1979 Jun; 1(8129):1258-61. PubMed ID: 87725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous subcutaneous insulin infusion (Mill-Hill Infuser) versus multiple injections (Medi-Jector) in the treatment of insulin-dependent diabetes mellitus and the effect of metabolic control on microangiopathy.
    Chiasson JL; Ducros F; Poliquin-Hamet M; Lopez D; Lecavalier L; Hamet P
    Diabetes Care; 1984; 7(4):331-7. PubMed ID: 6381006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.